Artificial neural networks in pancreatic disease

被引:47
作者
Bartosch-Harlid, A. [2 ]
Andersson, B. [1 ]
Aho, U. [1 ]
Nilsson, J. [3 ]
Andersson, R. [1 ]
机构
[1] Univ Lund Hosp, Dept Surg, SE-22185 Lund, Sweden
[2] Lund Univ, Dept Cell & Organism Biol, Lund, Sweden
[3] Univ Lund Hosp, Dept Cardiothorac Surg, Heart & Lung Ctr, SE-22185 Lund, Sweden
关键词
D O I
10.1002/bjs.6239
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: An artificial neural network (ANNs) is a non-linear pattern recognition technique that is rapidly gaining in popularity in medical decision-making. This study investigated the use of ANNs for diagnostic and prognostic purposes in pancreatic disease, especially acute pancreatitis and pancreatic cancer. Methods: PubMed was searched for articles on the use of ANNs in pancreatic diseases using the MeSH terms 'neural networks (computer)', 'pancreatic neoplasms', 'pancreatitis' and 'pancreatic diseases'. A systematic review of the articles was performed. Results: Eleven articles were identified, published between 1993 and 2007. The situations that lend themselves best to analysis by ANNs are complex multifactorial relationships, medical decisions when a second opinion is needed and when automated interpretation is required, for example in a situation of an inadequate number of experts. Conclusion: Conventional linear models have limitations in terms of diagnosis and prediction of outcome in acute pancreatitis and pancreatic cancer. Management of these disorders can be improved by applying ANNs to existing clinical parameters and newly established gene expression profiles.
引用
收藏
页码:817 / 826
页数:10
相关论文
共 69 条
[61]   Should serum pancreatic lipase replace serum amylase as a biomarker of acute pancreatitis? [J].
Smith, RC ;
Southwell-Keely, J ;
Chesher, D .
ANZ JOURNAL OF SURGERY, 2005, 75 (06) :399-404
[62]   Hepatic injury and pancreatitis during treatment with serotonin reuptake inhibitors:: data from the World Health Organization (WHO) database of adverse drug reactions [J].
Spigset, A ;
Hägg, S ;
Bate, A .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2003, 18 (03) :157-161
[63]   Incidence of cancer in the course of chronic pancreatitis [J].
Talamini, G ;
Falconi, M ;
Bassi, C ;
Sartori, N ;
Salvia, R ;
Caldiron, E ;
Frulloni, L ;
Di Francesco, V ;
Vaona, B ;
Bovo, P ;
Vantini, I ;
Pederzoli, P ;
Cavallini, G .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (05) :1253-1260
[64]  
Terwee CB, 2000, EUR J SURG, V166, P706
[65]  
Tu JV, 1998, MED DECIS MAKING, V18, P229
[66]   Prognostic factors in patients with metastatic pancreatic adenocarcinoma receiving systemic chemotherapy [J].
Ueno, H ;
Okada, S ;
Okusaka, T ;
Ikeda, M .
ONCOLOGY, 2000, 59 (04) :296-301
[67]   The inherited genetics of pancreatic cancer and prospects for secondary screening [J].
Vitone, LJ ;
Greenhalf, W ;
McFaul, CD ;
Ghaneh, P ;
Neoptolemos, JR .
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2006, 20 (02) :253-283
[68]   Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene [J].
Whitcomb, DC ;
Gorry, MC ;
Preston, RA ;
Furey, W ;
Sossenheimer, MJ ;
Ulrich, CD ;
Martin, SP ;
Gates, LK ;
Amann, ST ;
Toskes, PP ;
Liddle, R ;
McGrath, K ;
Uomo, G ;
Post, JC ;
Ehrlich, GD .
NATURE GENETICS, 1996, 14 (02) :141-145
[69]   Prognostic value of CA 19-9 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemcitabine [J].
Ziske, C ;
Schlie, C ;
Gorschlüter, M ;
Glasmacher, A ;
Mey, U ;
Strehl, J ;
Sauerbruch, T ;
Schmidt-Wolf, IGH .
BRITISH JOURNAL OF CANCER, 2003, 89 (08) :1413-1417